Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adipocyte membrane integrity via cold-induced apoptosis/crystallization" does **not** refer to a specific molecular target such as a receptor, enzyme, or transporter. Instead, it describes the **physical and cellular process** underlying cryolipolysis—a noninvasive cosmetic procedure that reduces subcutaneous fat by applying controlled cooling to induce selective injury to fat cells. During cryolipolysis, temperatures are lowered enough (-5°C to -10°C) to cause **crystallization of lipids within adipocytes**, leading to increased membrane permeability and subsequent cell stress. This triggers an apoptotic cascade—termed "cold-induced apoptosis"—that results in the gradual breakdown and removal of affected fat cells through an inflammatory response over several weeks. Importantly, this process is selective for adipocytes due to their higher sensitivity to cold compared with surrounding tissues like skin or muscle[2]. Because "adipocyte membrane integrity via cold-induced apoptosis/crystallization" refers broadly to a biophysical phenomenon rather than a discrete molecular entity, it is **not considered a canonical therapeutic target** in the sense used for drug discovery or pharmacology. There are no known drugs that interact with this "target"; instead, the effect is achieved through physical means. In summary: This entry does not correspond to any single molecule or receptor but rather describes the vulnerability of adipocytes' membranes under specific thermal conditions leading to programmed cell death—a principle exploited in body contouring procedures such as cryolipolysis[2].
Physical disruption of adipocyte membranes by cold-induced crystallization and ischemic injury[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adipocyte membrane integrity.